Sun Pharma.Inds.

Part of MojoOne Strategy

Market Cap: Large Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE044A01036
NSEID: SUNPHARMA
BSEID: 524715

INR

1,744.90

-1 (-0.06%)

BSENSE

Dec 19

BSE+NSE Vol: 30.45 lacs

Click here to access the older version

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,744.90",
    "chg": -1,
    "chgp": "-0.06%",
    "dir": -1,
    "prev_price": "1,745.90",
    "mcapval": "419,884.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE044A01036",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "30.45 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MS",
      "url": "https://www.marketsmojo.com/mojostocks#!#top10",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-1&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-nifty-50-membership-and-institutional-dynamics-3763498",
        "imagepath": "",
        "date": "2025-12-19 09:21:20",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Sun Pharmaceutical Industries among the elite group of companies that represent the Indian equity market’s core. This membership not only enhances the stock’s visibility but also ensures its inclusion in numerous index-tracking funds and institutional portfolios. The company’s market capitalisation of approximately ₹4,18,924 crores categorises it firmly as a large-cap stock, reinforcing its importance within the benchmark.</p>\n                <p>Sun Pharma’s presence in the index also means that its stock price movements can have a material impact on the overall index performance, especially given the pharmaceuticals and biotechnology sector’s weightage. This sector is a..."
      },
      {
        "title": "Sun Pharmaceutical Industries Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-hits-intraday-low-amid-price-pressure-3762668",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_priceRelatedfactors_3762668.png",
        "date": "2025-12-18 11:39:41",
        "description": "Sun Pharmaceutical Industries experienced a notable decline today, touching an intraday low of Rs 1,738.8 as the stock faced downward pressure amid a mixed market environment. The pharmaceutical giant underperformed its sector and the broader market, reflecting immediate selling interest and cautious sentiment among investors."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Heavy Put Option Activity Ahead of December Expiry",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-heavy-put-option-activity-amid-bearish-sentiment-3762416",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_most_active_stocks_puts_3762416.png",
        "date": "2025-12-18 10:00:13",
        "description": "Sun Pharmaceutical Industries Ltd has attracted significant attention in the options market, with put options seeing notable trading volumes and open interest as the 30 December 2025 expiry approaches. This activity reflects a cautious stance among investors amid recent price movements and sector dynamics."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Heavy Call Option Activity Ahead of December Expiry",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-heavy-call-option-activity-amid-mixed-price-action-3762415",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_most_active_stocks_calls_3762415.png",
        "date": "2025-12-18 10:00:13",
        "description": "Sun Pharmaceutical Industries has emerged as a focal point in the options market with significant call option trading activity observed ahead of the 30 December 2025 expiry. The pharmaceutical giant’s stock performance and option market dynamics suggest a notable positioning by investors anticipating potential price movements in the near term."
      },
      {
        "title": "Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-nifty-50-membership-amid-mixed-market-performance-3762107",
        "imagepath": "",
        "date": "2025-12-18 09:21:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Sun Pharmaceutical Industries in a select group of large-cap companies that represent the Indian equity market’s core. This membership not only enhances the stock’s visibility among domestic and international investors but also influences trading volumes and liquidity. Index funds and exchange-traded funds (ETFs) tracking the Nifty 50 are compelled to hold shares of Sun Pharma, thereby creating a steady demand irrespective of short-term market fluctuations.</p>\n                <p>Moreover, inclusion in the benchmark index often leads to increased scrutiny and expectations regarding corporate governance, financial transparency, and consistent performance. For Sun Pharmace..."
      },
      {
        "title": "Sun Pharmaceutical Industries: Analytical Perspective Shift Amid Mixed Technical and Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharmaceutical-industries-downgraded-to-buy-by-marketsmojo-amid-mixed-technical-signals-3760860",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_mojoScore_3760860.png",
        "date": "2025-12-17 08:22:15",
        "description": "Sun Pharmaceutical Industries has experienced a revision in its market assessment, reflecting nuanced changes across technical indicators, valuation metrics, financial trends, and overall quality parameters. This article examines the factors influencing the recent analytical perspective shift, providing investors with a comprehensive understanding of the company’s current standing within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sun Pharmaceutical Industries: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-nifty-50-membership-amid-mixed-market-performance-3759775",
        "imagepath": "",
        "date": "2025-12-16 09:21:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Sun Pharmaceutical Industries in a prominent position within India’s equity market. This membership not only reflects the company’s substantial market capitalisation, currently standing at approximately ₹4,28,317.28 crores, but also underscores its influence on index movements and investor sentiment. The Nifty 50 serves as a benchmark for many institutional and retail investors, making the stock’s performance a barometer for the Pharmaceuticals & Biotechnology sector’s health.</p>\n                <p>Sun Pharma’s inclusion in this elite group ensures heightened visibility and liquidity, factors that often attract significant institutional participation. The company’s mark..."
      },
      {
        "title": "Sun Pharmaceutical Industries: Technical Momentum Shift Signals Mixed Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-technical-momentum-shifts-amid-mixed-market-signals-3758316",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_technicaldot_3758316.png",
        "date": "2025-12-15 08:04:43",
        "description": "Sun Pharmaceutical Industries has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and mildly bearish signals across multiple timeframes. This development invites a closer examination of key technical indicators such as MACD, RSI, moving averages, and volume trends to understand the stock’s current market positioning and potential trajectory."
      },
      {
        "title": "Sun Pharmaceutical Industries: Analytical Perspective Shift Highlights Key Investment Factors",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharmaceutical-industries-upgraded-to-strong-buy-on-robust-fundamentals-and-technicals-3757140",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_mojoScore_3757140.png",
        "date": "2025-12-12 08:11:55",
        "description": "Sun Pharmaceutical Industries has recently undergone a revision in its market assessment, reflecting changes across multiple evaluation parameters including quality, valuation, financial trends, and technical indicators. This article explores the underlying data and market context that have influenced this shift, providing investors with a comprehensive understanding of the company’s current standing within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 911,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding Intimation under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
      "source": "NSE",
      "caption": "Sun Pharmaceutical Industries Limited - Other General Purpose",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 06, 2019, titled \"Sun Pharma and AstraZeneca enter into License Agreement for Novel Oncology products in China\".",
      "source": "NSE",
      "caption": "Sun Pharmaceutical Industries Limited - Press Release",
      "datetime": "06-Nov-2019"
    },
    {
      "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Please find enclosed Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018'.",
      "source": "NSE",
      "caption": "Sun Pharmaceutical Industries Limited - Updates",
      "datetime": "18-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>550%</strong> dividend, ex-date: 07 Jul 25",
          "dt": "2025-07-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-19 09:21:20

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Sun Pharmaceutical Industries among the elite group of companies that represent the Indian equity market’s core. This membership not only enhances the stock’s visibility but also ensures its inclusion in numerous index-tracking funds and institutional portfolios. The company’s market capitalisation of approximately ₹4,18,924 crores categorises it firmly as a large-cap stock, reinforcing its importance within the benchmark.

Sun Pharma’s presence in the index also means that its stock price movements can have a material impact on the overall index performance, especially given the pharmaceuticals and biotechnology sector’s weightage. This sector is a...

Sun Pharmaceutical Industries Hits Intraday Low Amid Price Pressure

2025-12-18 11:39:41

Sun Pharmaceutical Industries experienced a notable decline today, touching an intraday low of Rs 1,738.8 as the stock faced downward pressure amid a mixed market environment. The pharmaceutical giant underperformed its sector and the broader market, reflecting immediate selling interest and cautious sentiment among investors.

Sun Pharmaceutical Industries Sees Heavy Put Option Activity Ahead of December Expiry

2025-12-18 10:00:13

Sun Pharmaceutical Industries Ltd has attracted significant attention in the options market, with put options seeing notable trading volumes and open interest as the 30 December 2025 expiry approaches. This activity reflects a cautious stance among investors amid recent price movements and sector dynamics.

Sun Pharmaceutical Industries Sees Heavy Call Option Activity Ahead of December Expiry

2025-12-18 10:00:13

Sun Pharmaceutical Industries has emerged as a focal point in the options market with significant call option trading activity observed ahead of the 30 December 2025 expiry. The pharmaceutical giant’s stock performance and option market dynamics suggest a notable positioning by investors anticipating potential price movements in the near term.

Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-18 09:21:17

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Sun Pharmaceutical Industries in a select group of large-cap companies that represent the Indian equity market’s core. This membership not only enhances the stock’s visibility among domestic and international investors but also influences trading volumes and liquidity. Index funds and exchange-traded funds (ETFs) tracking the Nifty 50 are compelled to hold shares of Sun Pharma, thereby creating a steady demand irrespective of short-term market fluctuations.

Moreover, inclusion in the benchmark index often leads to increased scrutiny and expectations regarding corporate governance, financial transparency, and consistent performance. For Sun Pharmace...

Sun Pharmaceutical Industries: Analytical Perspective Shift Amid Mixed Technical and Financial Signals

2025-12-17 08:22:15

Sun Pharmaceutical Industries has experienced a revision in its market assessment, reflecting nuanced changes across technical indicators, valuation metrics, financial trends, and overall quality parameters. This article examines the factors influencing the recent analytical perspective shift, providing investors with a comprehensive understanding of the company’s current standing within the Pharmaceuticals & Biotechnology sector.

Sun Pharmaceutical Industries: Navigating Nifty 50 Membership and Market Dynamics

2025-12-16 09:21:01

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Sun Pharmaceutical Industries in a prominent position within India’s equity market. This membership not only reflects the company’s substantial market capitalisation, currently standing at approximately ₹4,28,317.28 crores, but also underscores its influence on index movements and investor sentiment. The Nifty 50 serves as a benchmark for many institutional and retail investors, making the stock’s performance a barometer for the Pharmaceuticals & Biotechnology sector’s health.

Sun Pharma’s inclusion in this elite group ensures heightened visibility and liquidity, factors that often attract significant institutional participation. The company’s mark...

Sun Pharmaceutical Industries: Technical Momentum Shift Signals Mixed Market Sentiment

2025-12-15 08:04:43

Sun Pharmaceutical Industries has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and mildly bearish signals across multiple timeframes. This development invites a closer examination of key technical indicators such as MACD, RSI, moving averages, and volume trends to understand the stock’s current market positioning and potential trajectory.

Sun Pharmaceutical Industries: Analytical Perspective Shift Highlights Key Investment Factors

2025-12-12 08:11:55

Sun Pharmaceutical Industries has recently undergone a revision in its market assessment, reflecting changes across multiple evaluation parameters including quality, valuation, financial trends, and technical indicators. This article explores the underlying data and market context that have influenced this shift, providing investors with a comprehensive understanding of the company’s current standing within the Pharmaceuticals & Biotechnology sector.

View All News

Announcement

Sun Pharmaceutical Industries Limited - Other General Purpose

09-Dec-2019 | Source : NSE

Sun Pharmaceutical Industries Limited has informed the Exchange regarding Intimation under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Sun Pharmaceutical Industries Limited - Press Release

06-Nov-2019 | Source : NSE

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 06, 2019, titled "Sun Pharma and AstraZeneca enter into License Agreement for Novel Oncology products in China".

Sun Pharmaceutical Industries Limited - Updates

18-Oct-2019 | Source : NSE

Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Please find enclosed Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018'.